Fernanda P Silveira, Md, Ms
Clinical trials sponsored by Fernanda P Silveira, Md, Ms, explained in plain language.
-
Can an antibody boost help transplant patients beat CMV faster?
Disease control ENROLLING_BY_INVITATIONThis trial tests whether adding a single dose of CytoGam—a concentrated antibody product against cytomegalovirus (CMV)—to standard antiviral drugs helps clear CMV from the blood faster in solid organ transplant recipients. The study enrolls adults aged 18–75 who have received an …
Phase: PHASE4 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New antifungal drug could shield liver transplant patients from deadly infections
Disease control ENROLLING_BY_INVITATIONThis study tests whether a new antifungal drug called rezafungin can prevent serious fungal infections in people who have had a liver transplant. About 385 adults at high risk for infection will receive the drug, and their outcomes will be compared to similar patients from the pa…
Phase: PHASE3 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC